Literature DB >> 26847830

Non-Coding RNAs in Thyroid Cancer.

Ranran Zhang1, Heather Hardin1, Jidong Chen1, Zhenying Guo1, Ricardo V Lloyd2.   

Abstract

Non-coding (nc)RNAs are divided into small ncRNAs and long ncRNAs (lncRNAs). MicroRNAs (miRNAs) are small ncRNAS which are around 22 nucleotides in length that mediate post-transcriptional gene silencing. LncRNAs are greater than 200 bp in length. Each ncRNA can have multiple targets and can be regulated by multiple genetic factors. Because ncRNAs are not translated into proteins, they can only be detected at the nucleic acid level by in situ hybridization, by RT-PCR, or by sequencing which makes their detection more challenging in the routine pathology laboratory. A great deal of new information has accumulated about miRNAs in thyroid tissues during the past decade. Some of these studies have shown that deregulation of miRNAs may be useful in diagnostic pathology. Information about the role of lncRNA in the development of thyroid tumors is in the early stages of development, but new information is accumulating rapidly. In this review, we will discuss the recent progress in our understanding of the relationship between ncRNAs and the development of thyroid cancers and the potential uses of ncRNAs in the diagnosis and prognosis of thyroid tumors.

Entities:  

Keywords:  In situ hybridization; MicroRNA; Non-coding RNA; Thyroid; Thyroid carcinoma; lncRNA

Mesh:

Substances:

Year:  2016        PMID: 26847830     DOI: 10.1007/s12022-016-9417-8

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  63 in total

1.  KEGG: kyoto encyclopedia of genes and genomes.

Authors:  M Kanehisa; S Goto
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  The eukaryotic genome as an RNA machine.

Authors:  Paulo P Amaral; Marcel E Dinger; Tim R Mercer; John S Mattick
Journal:  Science       Date:  2008-03-28       Impact factor: 47.728

Review 3.  Non-coding RNAs: regulators of disease.

Authors:  Ryan J Taft; Ken C Pang; Timothy R Mercer; Marcel Dinger; John S Mattick
Journal:  J Pathol       Date:  2010-01       Impact factor: 7.996

Review 4.  MicroRNA history: discovery, recent applications, and next frontiers.

Authors:  Maria I Almeida; Rui M Reis; George A Calin
Journal:  Mutat Res       Date:  2011-03-30       Impact factor: 2.433

5.  Genome-wide analysis of long noncoding RNA expression profile in papillary thyroid carcinoma.

Authors:  Xiabin Lan; Hao Zhang; Zhihong Wang; Wenwu Dong; Wei Sun; Liang Shao; Ting Zhang; Dalin Zhang
Journal:  Gene       Date:  2015-05-21       Impact factor: 3.688

Review 6.  Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review).

Authors:  Alessandro Allegra; Andrea Alonci; Salvatore Campo; Giuseppa Penna; Annamaria Petrungaro; Demetrio Gerace; Caterina Musolino
Journal:  Int J Oncol       Date:  2012-10-01       Impact factor: 5.650

7.  MiR-99a Inhibits Cell Proliferation and Tumorigenesis through Targeting mTOR in Human Anaplastic Thyroid Cancer.

Authors:  Hou-Gang Huang; Xi Luo; Shuai Wu; Bin Jian
Journal:  Asian Pac J Cancer Prev       Date:  2015

8.  MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer.

Authors:  James C Lee; Jing Ting Zhao; Roderick J Clifton-Bligh; Anthony Gill; Justin S Gundara; Julian C Ip; Anthony Glover; Mark S Sywak; Leigh W Delbridge; Bruce G Robinson; Stanley B Sidhu
Journal:  Cancer       Date:  2013-10-28       Impact factor: 6.860

Review 9.  The genetic signatures of noncoding RNAs.

Authors:  John S Mattick
Journal:  PLoS Genet       Date:  2009-04-24       Impact factor: 5.917

10.  BRAF-Activated Long Noncoding RNA Modulates Papillary Thyroid Carcinoma Cell Proliferation through Regulating Thyroid Stimulating Hormone Receptor.

Authors:  Haitao Zheng; Meng Wang; Lixin Jiang; Haidi Chu; Jinchen Hu; Jinyao Ning; Baoyuan Li; Dong Wang; Jie Xu
Journal:  Cancer Res Treat       Date:  2015-08-12       Impact factor: 4.679

View more
  21 in total

1.  Long Non-coding RNA Expression in Anaplastic Thyroid Carcinomas.

Authors:  Yanping Wang; Heather Hardin; Ying-Hsia Chu; Karla Esbona; Ranran Zhang; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2019-12       Impact factor: 3.943

2.  Phosphorylated Mechanistic Target of Rapamycin (p-mTOR) and Noncoding RNA Expression in Follicular and Hürthle Cell Thyroid Neoplasm.

Authors:  Adam Covach; Sanjay Patel; Heather Hardin; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2017-09       Impact factor: 3.943

Review 3.  Altered Epigenetic Mechanisms in Thyroid Cancer Subtypes.

Authors:  Maryam Zarkesh; Azita Zadeh-Vakili; Fereidoun Azizi; Forough Foroughi; Maziar Mohammad Akhavan; Mehdi Hedayati
Journal:  Mol Diagn Ther       Date:  2018-02       Impact factor: 4.074

4.  Transcript-level regulation of MALAT1-mediated cell cycle and apoptosis genes using dual MEK/Aurora kinase inhibitor "BI-847325" on anaplastic thyroid carcinoma.

Authors:  Hilda Samimi; Vahid Haghpanah; Shiva Irani; Ehsan Arefian; Alireza Naderi Sohi; Parviz Fallah; Masoud Soleimani
Journal:  Daru       Date:  2019-05-10       Impact factor: 3.117

Review 5.  Serum miRNAs as Biomarkers for the Diagnosis and Prognosis of Thyroid Cancer: A Comprehensive Review of the Literature.

Authors:  Mohammad-Reza Mahmoudian-Sani; Ameneh Mehri-Ghahfarrokhi; Majid Asadi-Samani; Gholam-Reza Mobini
Journal:  Eur Thyroid J       Date:  2017-04-07

6.  MALAT1 Long Non-coding RNA Expression in Thyroid Tissues: Analysis by In Situ Hybridization and Real-Time PCR.

Authors:  Ranran Zhang; Heather Hardin; Wei Huang; Jidong Chen; Sofia Asioli; Alberto Righi; Francesca Maletta; Anna Sapino; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2017-03       Impact factor: 3.943

7.  A novel RNA sequencing-based risk score model to predict papillary thyroid carcinoma recurrence.

Authors:  Jingni He; Zhong Tian; Xu Yao; Baiyu Yao; Yuan Liu; Jiapeng Yang
Journal:  Clin Exp Metastasis       Date:  2019-12-02       Impact factor: 5.150

8.  Molecular Network-Based Identification of Competing Endogenous RNAs in Thyroid Carcinoma.

Authors:  Minjia Lu; Xingyu Xu; Baohang Xi; Qi Dai; Chenli Li; Li Su; Xiaonan Zhou; Min Tang; Yuhua Yao; Jialiang Yang
Journal:  Genes (Basel)       Date:  2018-01-19       Impact factor: 4.096

9.  RNA-sequencing investigation identifies an effective risk score generated by three novel lncRNAs for the survival of papillary thyroid cancer patients.

Authors:  Yi-Huan Luo; Liang Liang; Rong-Quan He; Dong-Yue Wen; Guo-Fei Deng; Hong Yang; Yun He; Wei Ma; Xiao-Yong Cai; Jun-Qiang Chen; Gang Chen
Journal:  Oncotarget       Date:  2017-05-26

10.  Identification of novel diagnostic biomarkers for thyroid carcinoma.

Authors:  Xiliang Wang; Qing Zhang; Zhiming Cai; Yifan Dai; Lisha Mou
Journal:  Oncotarget       Date:  2017-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.